Silvia Mignozzi, Claudia Santucci, Gianfranco Alicandro, et al. Cancer Causes Control. 2026 Apr 3;37(5):79
An increasing cancer incidence has been observed among recent generations over the last decade. However, apart from colorectal cancer, these increases were not associated with rises in mortality. We extracted death counts for indi...
Read More
Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al.Health Sci Rep. 2024 Aug 21;7(8):e70002
Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. The data from 3...
Read More
In recent years, the incidence of early-onset cancers among individuals under 50 years of age has been on the rise. From 1990 to 2021, the incidence rate of all early-onset cancers in China increased by 150.72 per 100,000, while t...
Read More
Elyesa Ünal, Elena Goodchild, Volker Winkler, et al. Arch Public Health. 2025 Oct 13;83(1):243
Lung Cancer is one of the four most frequent malignant neoplasms in the world, and first in mortality. In 2020, lung cancer resulted in roughly 1.8 million deaths globally. Lung cancer is a major public health problem in low and l...
Read More
Stephen Lam,David R. Baldwin, Anand Devaraj, et al. Journal of Thoracic Oncology Vol. 21 No. 2: 235–252
In the past two decades, lung cancer screening (LCS) with low-dose computed tomography (LDCT) has emerged as one of the most effective strategies for reducing lung cancer mortality. Landmark trials, including NLST and NELSON, demo...
Read More
Kevin Chiu, Joanna P MacEwan, Suepattra G May, et al. MDM Policy Pract. 2022 Aug 3;7(2)
Cancer can have a profound impact on productivity. Traditional approaches to capturing health-related productivity loss focus only on the foregone wages of affected patients, overlooking the losses caregivers can incur. This study...
Read More
Cancer imposes a substantial economic burden on patients that may be worse in patients with higher-stage disease due to the need for more therapy. The cohort consisted of 46,158 patients (mean age at diagnosis, 46 years; 30,...
Read More
Ziting Wu , Yiwen Yu, Feng Xie, et al. BMC Health Serv Res. 2024 Sep 27;24(1): 1135
China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. This study aims to estimate the financial burden borne by patients and analyze the cost compositions of the leading cancers with th...
Read More
Aug.Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al. Health Sci Rep. 2024 Aug 21;7(8):e70002
Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. According to so...
Read More
Cancer imposes a substantial economic burden on patients that may be worse in patients with higher-stage disease due to the need for more therapy. This retrospective cohort study used administrative claims data of a large national...
Read More
Agnes Brandtmüller , Anne Meiwald , Peter Toth , et al. J Med Econ 2026 Dec;29(1):785-798
Cancer imposes a substantial clinical and economic burden across Europe. This analysis estimated the lost productivity cost of the five cancer types with the highest premature mortality and five cancer types with the highest morbi...
Read More
Marta Ortega Ortega, Paul Hanly, Alison Pearce, et al. Applied Health Economics and Health Policy (2023) 21:877–889
Between 2018 and 2040, cancer is expected to cause around eight million premature deaths (58% male). The cumulative projected productivity costs in this respect are €1.3 trillion, representing an annual average of €58.7 billion, o...
Read More